α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Neurodegenerative Diseases ; 14 (2013), 1. - S. 1-17. - ISSN 1660-2854. - eISSN 1660-2862
- Keyword
-
Parkinson-Krankheit
Substantia nigra
Synuclein
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2013
- Creator
-
Eschbach, Judith
Danzer, Karin M.
- DOI
-
10.18725/OPARU-40456
- URN
-
urn:nbn:de:bsz:289-oparu-40532-6
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eschbach, Judith
- Danzer, Karin M.
- Universität Ulm
Time of origin
- 2013
Other Objects (12)
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease